newsfilter
← Latest News
Business Wire·

Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program

- The Company is evaluating non-hallucinogenic dosing of CYB005 preclinical candidate molecules for the treatment of CNS disorders - - Cybin's sector-leading intellectual property portfolio now includes over 70 granted